First, there is simply no component data supporting indefinite, continuous, year-round use the honest position is that nobody has studied that, so the protocol builds in a stop
Afamelanotide (Scenesse, Clinuvel Pharmaceuticals) is a linear MC1R selective tridecapeptide, approved by the FDA on October 8, 2019, and by the EMA on December 22, 2014, exclusively for the treatment of erythropoietic protoporphyria (EPP) in adults
The FDA-approved escalation schedule requires weekly injections to safely increase doses and monitor tolerance
Also, NAC is increasingly difficult to find on store shelves
According to research, reducing just 12% of body fat can increase a persons lifespan by 6.8 years
Imaging 17 , e016525 (2024)